LipoGlo: A sensitive and specific reporter of atherogenic lipoproteins
暂无分享,去创建一个
[1] T. Rana,et al. Lipoprotein lipase regulates hematopoietic stem progenitor cell maintenance through DHA supply , 2018, Nature Communications.
[2] Audrey Y. Chu,et al. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol , 2017, Journal of the American Heart Association.
[3] K. Ebina,et al. Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein , 2017, European Biophysics Journal.
[4] Amnon Schlegel. Zebrafish Models for Dyslipidemia and Atherosclerosis Research , 2016, Front. Endocrinol..
[5] R. Hegele,et al. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol , 2016, Diabetes.
[6] Olle Melander,et al. Apolipoproteins, lipids and risk of cancer , 2016, International journal of cancer.
[7] R. Mahley. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[8] Stephen C. Ekker,et al. FusX: A Rapid One-Step Transcription Activator-Like Effector Assembly System for Genome Science , 2016, Human gene therapy.
[9] P. Hall,et al. Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing , 2016, The Journal of Immunology.
[10] A. Remaley,et al. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia , 2015, Disease Models & Mechanisms.
[11] K. Feingold,et al. Introduction to Lipids and Lipoproteins , 2015 .
[12] S. Farber,et al. Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake , 2015, Disease Models & Mechanisms.
[13] Michael R. Taylor,et al. Functional and genetic analysis of choroid plexus development in zebrafish , 2014, Front. Neurosci..
[14] D. Nickerson,et al. A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians , 2014, bioRxiv.
[15] May E. Montasser,et al. Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S] , 2014, Journal of Lipid Research.
[16] L. Solnica-Krezel,et al. Efficient homologous recombination-mediated genome engineering in zebrafish using TALE nucleases , 2014, Development.
[17] C. Curcio,et al. Cholesterol in the retina: The best is yet to come , 2014, Progress in Retinal and Eye Research.
[18] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[19] S. Farber,et al. Zebrafish yolk lipid processing: a tractable tool for the study of vertebrate lipid transport and metabolism , 2014, Disease Models & Mechanisms.
[20] R. McLeod,et al. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion , 2014, Journal of biomedical research.
[21] Steven A. Harvey,et al. A systematic genome-wide analysis of zebrafish protein-coding gene function , 2013, Nature.
[22] G. Ren,et al. Optimized negative-staining protocol for examining lipid-protein interactions by electron microscopy. , 2013, Methods in molecular biology.
[23] Stephen C. Ekker,et al. Mojo Hand, a TALEN design tool for genome editing applications , 2013, BMC Bioinformatics.
[24] S. Yusuf,et al. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study. , 2012, Atherosclerosis.
[25] Matthew A. Hibbs,et al. Pla2g12b and Hpn Are Genes Identified by Mouse ENU Mutagenesis That Affect HDL Cholesterol , 2012, PloS one.
[26] Brock F. Binkowski,et al. Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.
[27] Tom T. Chen,et al. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1 , 2012, Nature Medicine.
[28] S. Siddiqi,et al. Intracellular Trafficking and Secretion of VLDL , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[29] S. Farber,et al. Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish. , 2011, Developmental biology.
[30] M. Malbouyres,et al. Development of the zebrafish myoseptum with emphasis on the myotendinous junction , 2011, Cell and Tissue Research.
[31] D. Kretzschmar,et al. A Gateway MultiSite Recombination Cloning Toolkit , 2011, PloS one.
[32] T. Jacobson. Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk. , 2011, Mayo Clinic proceedings.
[33] Chi-wai Wong,et al. Hepatocyte nuclear factor‐4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A2 GXIIB , 2011, Hepatology.
[34] B. Zinman,et al. Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. , 2010, Clinical chemistry.
[35] Y. Bashmakov,et al. ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line. , 2010, World journal of hepatology.
[36] P. Ridker,et al. Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis , 2009, PLoS genetics.
[37] M. Argyropoulou,et al. Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. , 2009, Atherosclerosis.
[38] H. Korswagen,et al. Mammalian Wnt3a is Released on Lipoprotein Particles , 2009, Traffic.
[39] R. Lakshmy,et al. A rapid 3% polyacrylamide slab gel electrophoresis method for high through put screening of LDL phenotype , 2008, Lipids in Health and Disease.
[40] Steven Hawken,et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.
[41] I. Godsland,et al. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis This research was supported by a grant from GlaxoSmithKline. Published, JLR Papers in Press, March 12, 2008. , 2008, Journal of Lipid Research.
[42] P. Ingham,et al. Modeling cardiovascular disease in the zebrafish. , 2008, Trends in cardiovascular medicine.
[43] N. Trede,et al. Method for isolation of PCR-ready genomic DNA from zebrafish tissues. , 2007, BioTechniques.
[44] J. Borén,et al. Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .
[45] Richard E Gregg,et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. , 2007, The New England journal of medicine.
[46] M. Rizzo,et al. Low-density lipoprotein size and cardiovascular risk assessment. , 2006, QJM : monthly journal of the Association of Physicians.
[47] Kenny K. Wong,et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] James G. Bollinger,et al. Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. , 2003, Biochemistry.
[49] M. Hussain,et al. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.R200014-JLR200 , 2003, Journal of Lipid Research.
[50] R. Krauss,et al. Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 , 2002, Journal of Lipid Research.
[51] J. Borén,et al. The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100* , 2001, The Journal of Biological Chemistry.
[52] J. Mcconnell,et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. , 2001, Clinical chemistry.
[53] G. Chrousos,et al. Introduction to Lipids and Lipoproteins -- Endotext , 2000 .
[54] N. Davidson,et al. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. , 2000, Annual review of nutrition.
[55] P. Chowienczyk,et al. LDL particle size: an important drug target? , 1999, British journal of clinical pharmacology.
[56] L. Havekes,et al. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[57] G. S. Shelness,et al. Amino Acids 430–570 in Apolipoprotein B Are Critical for Its Binding to Microsomal Triglyceride Transfer Protein* , 1998, The Journal of Biological Chemistry.
[58] L. Fenart,et al. A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.
[59] M. Westerfield. The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .
[60] Y. Arad,et al. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. , 1992, Journal of lipid research.
[61] V. Schumaker,et al. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. , 1988, Journal of lipid research.
[62] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[63] J. Kane,et al. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. , 1980, Proceedings of the National Academy of Sciences of the United States of America.